ISCOMATRIX (TM) adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza
Andrea A Timothy, Ana Tokanovic, Kenneth J Snibson, Stirling J Edwards, Martin J Pearse, Jean-Pierre Y Scheerlinck, Philip Sutton
Human Vaccines & Immunotherapeutics | TAYLOR & FRANCIS INC | Published : 2015
Awarded by Australian Research Council of Australia
This work was supported by the Victorian Government's Operational Infrastructure Support Program and by Linkage Project grant LP100200728 from the Australian Research Council of Australia. PS is supported by a Senior Research Fellowship from the National Health and Medical Research Council of Australia.